HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Bastian Hengerer Selected Research
Bastian Hengerer Research Topics
Disease
21
Parkinson Disease (Parkinson's Disease)
01/2021 - 05/2004
6
Neurodegenerative Diseases (Neurodegenerative Disease)
03/2016 - 06/2007
5
Dyskinesias (Dyskinesia)
01/2021 - 04/2008
5
Dementia (Dementias)
01/2017 - 01/2009
5
Alzheimer Disease (Alzheimer's Disease)
08/2014 - 06/2007
4
Tics (Tic)
01/2021 - 01/2013
3
Major Depressive Disorder (Major Depressive Disorders)
01/2024 - 01/2017
3
Mental Disorders (Mental Disorder)
01/2021 - 01/2019
3
Synucleinopathies
07/2014 - 10/2009
2
Tourette Syndrome (Tourette's Syndrome)
01/2018 - 01/2013
2
Inflammation (Inflammations)
05/2016 - 10/2014
2
Fatigue
11/2015 - 10/2014
1
Psychotic Disorders (Schizoaffective Disorder)
01/2023
1
Frontotemporal Dementia (Semantic Dementia)
01/2019
1
Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2018
1
Cognitive Dysfunction
01/2017
1
Neoplasms (Cancer)
09/2016
1
Shock
05/2016
1
Weight Loss (Weight Reduction)
11/2015
1
Disease Progression
07/2014
1
Tic Disorders (Tic Disorder)
01/2013
1
Catalepsy
08/2010
1
Lewy Body Disease (Lewy Body Dementia)
07/2010
1
Parkinsonian Disorders (Parkinsonism)
07/2010
1
Mitochondrial Diseases (Mitochondrial Disease)
07/2010
1
Multiple System Atrophy
01/2009
1
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2009
1
Amyloid Plaque
02/2007
1
Stroke (Strokes)
05/2004
Drug/Important Bio-Agent (IBA)
9
alpha-Synuclein
IBA
03/2016 - 08/2007
7
Proteins (Proteins, Gene)
FDA Link
12/2020 - 06/2007
7
Biomarkers (Surrogate Marker)
IBA
01/2019 - 05/2008
6
Synucleins
IBA
01/2016 - 05/2008
4
Levodopa (L Dopa)
FDA Link
Generic
01/2021 - 04/2008
4
Dopamine (Intropin)
FDA Link
Generic
10/2014 - 10/2004
3
Riluzole
FDA Link
Generic
01/2021 - 01/2018
3
Kynurenine
IBA
01/2017 - 05/2016
3
Amyloid (Amyloid Fibrils)
IBA
08/2014 - 01/2012
2
Antidepressive Agents (Antidepressants)
IBA
01/2024 - 01/2023
2
Dopamine Antagonists
IBA
01/2018 - 01/2013
2
Cytokines
IBA
11/2015 - 05/2004
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
11/2015 - 05/2004
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
10/2014 - 07/2014
2
Peptides (Polypeptides)
IBA
08/2014 - 01/2012
2
Proteasome Endopeptidase Complex (Proteasome)
IBA
07/2010 - 06/2007
2
Amyloid beta-Peptides
IBA
12/2007 - 02/2007
1
Ketamine
FDA Link
Generic
01/2024
1
Esketamine
IBA
01/2023
1
Glucocorticoids
IBA
01/2021
1
Oxidopamine (6 Hydroxydopamine)
IBA
01/2021
1
Cytoskeletal Proteins
IBA
01/2019
1
Protons (Proton)
IBA
01/2018
1
Aripiprazole (Abilify)
FDA Link
01/2018
1
Bicuculline
IBA
01/2018
1
Clonidine (ST 155)
FDA Link
Generic
01/2018
1
Indicators and Reagents (Reagents)
IBA
01/2018
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
01/2017
1
Tryptophan (L-Tryptophan)
FDA Link
05/2016
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
05/2016
1
Enzymes
IBA
05/2016
1
telomerase RNA (bTR)
IBA
01/2016
1
Saccharin
IBA
11/2015
1
Apomorphine
FDA Link
07/2014
1
Quinpirole
IBA
07/2014
1
Leucine (L-Leucine)
FDA Link
03/2013
1
Phosphotransferases (Kinase)
IBA
03/2013
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
04/2012
1
Netrins
IBA
04/2012
1
alpha 1-Antitrypsin (alpha 1 Antitrypsin)
IBA
01/2012
1
AMPA Receptors (AMPA Receptor)
IBA
06/2011
1
Calcium
IBA
06/2011
1
Haloperidol (Haldol)
FDA Link
Generic
08/2010
1
Glutamic Acid (Glutamate)
FDA Link
08/2010
1
baicalein
IBA
07/2010
1
Isradipine (Dynacirc)
FDA Link
Generic
03/2009
1
MicroRNAs (MicroRNA)
IBA
05/2008
1
Mitogen-Activated Protein Kinases
IBA
04/2008
1
Mitogen-Activated Protein Kinase 3
IBA
04/2008
1
Lovastatin (Mevacor)
FDA Link
Generic
04/2008
1
3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)
IBA
04/2008
1
Oxidoreductases (Dehydrogenase)
IBA
04/2008
1
Ubiquitin
IBA
06/2007
1
Proteome
IBA
02/2007
1
Dopamine Agents (Dopaminergic Agents)
IBA
10/2006
1
oxamyl
IBA
05/2004
1
Caspase Inhibitors
IBA
05/2004
1
Dipeptides
IBA
05/2004
1
1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
IBA
05/2004
Therapy/Procedure
3
Therapeutics
07/2014 - 10/2006
1
Cognitive Training
01/2017
1
Oral Administration
08/2010
1
Denervation
03/2009